About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Pediatric Pulmonology
›
top-articles
Pediatric Pulmonology
2.4
(top 20%)
impact factor
7.2K
(top 5%)
papers
149.6K
(top 5%)
citations
120
(top 5%)
h
-index
2.5
(top 20%)
impact factor
9.8K
all documents
157.1K
doc citations
169
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
Pediatric Pulmonology
2002
910
2
Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults
Pediatric Pulmonology
2020
791
3
Pseudomonas aeruginosa
biofilms in the respiratory tract of cystic fibrosis patients
Pediatric Pulmonology
2009
685
4
Recombinant Human Deoxyribonuclease Shortens Ventilation Time in Young, Mechanically Ventilated Children
Pediatric Pulmonology
2006
605
5
Pulmonary function between 6 and 18 years of age
Pediatric Pulmonology
1993
593
6
Respiration rate monitoring methods: A review
Pediatric Pulmonology
2011
395
7
Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition
Pediatric Pulmonology
2001
380
8
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis
Pediatric Pulmonology
2001
361
9
MucoidPseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
Pediatric Pulmonology
1992
346
10
The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis
Pediatric Pulmonology
1995
320
11
Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review
Pediatric Pulmonology
2016
297
12
Glucocorticoids and lung development in the fetus and preterm infant
Pediatric Pulmonology
2001
262
13
Polysomnographic values in children 2-9 years old: Additional data and review of the literature
Pediatric Pulmonology
2005
261
14
Pulmonary cysts in early childhood and the risk of malignancy
Pediatric Pulmonology
2009
257
15
Vitamin D deficiency in young children with severe acute lower respiratory infection
Pediatric Pulmonology
2009
256
16
Global strategy for the diagnosis and management of asthma in children 5 years and younger
Pediatric Pulmonology
2011
243
17
Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis
Pediatric Pulmonology
2008
239
18
Prevalence of asthma-like symptoms in young children
Pediatric Pulmonology
2007
237
19
Ventricular dysfunction in children with obstructive sleep apnea: Radionuclide assessment
Pediatric Pulmonology
1988
233
20
Respiratory syncytial virus hospitalization and mortality: Systematic review and meta‐analysis
Pediatric Pulmonology
2017
229
21
Randomized controlled study of in-hospital exercise training programs in children with cystic fibrosis
Pediatric Pulmonology
2002
228
22
Body-mass index as a predictor of incident asthma in a prospective cohort of children
Pediatric Pulmonology
2003
228
23
The global burden of respiratory disease-Impact on child health
Pediatric Pulmonology
2014
221
24
Pulmonary exacerbations in cystic fibrosis
Pediatric Pulmonology
2004
215
25
Evaluation of neonatal pulmonary mechanics and energetics: A two factor least mean square analysis
Pediatric Pulmonology
1988
214
26
Clinical manifestations of children with COVID‐19: A systematic review
Pediatric Pulmonology
2020
213
27
Sleep and breathing in Prader-Willi syndrome
Pediatric Pulmonology
2002
211
28
Pulmonary exacerbations are associated with subsequent FEV
1
decline in both adults and children with cystic fibrosis
Pediatric Pulmonology
2011
211
29
Clinical characteristics of COVID‐19 in children: A systematic review
Pediatric Pulmonology
2020
207
30
Spinal muscular atrophy type 1: Management and outcomes
Pediatric Pulmonology
2002
205
31
Lower Airway Inflammation in Infants with Cystic Fibrosis Detected by Newborn Screening
Pediatric Pulmonology
2005
205
32
Presence of cystic fibrosis‐related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis
Pediatric Pulmonology
2001
203
33
Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia
Pediatric Pulmonology
2005
201
34
Liquid ventilation
Pediatric Pulmonology
1992
200
35
Anti‐inflammatory effects of macrolides in lung disease
Pediatric Pulmonology
2001
194
36
Association of apnea and nonacid gastroesophageal reflux in infants: Investigations with the intraluminal impedance technique
Pediatric Pulmonology
2001
190
37
Inflammation in cystic fibrosis: An update
Pediatric Pulmonology
2018
187
38
Spirometric reference values for white European children and adolescents: Polgar revisited
Pediatric Pulmonology
1995
186
39
Plastic bronchitis in children: A case series and review of the medical literature
Pediatric Pulmonology
2002
185
40
High‐flow nasal cannula: Impact on oxygenation and ventilation in an acute lung injury model
Pediatric Pulmonology
2011
185
41
Polysomnography in obese children with a history of sleep-associated breathing disorders
Pediatric Pulmonology
1993
182
42
Pediatric asthma deaths in Victoria: The mild are at risk
Pediatric Pulmonology
1992
177
43
The role of inflammation in the pathogenesis of bronchopulmonary dysplasia
Pediatric Pulmonology
1995
177
44
Foreign body aspiration: What is the outcome?
Pediatric Pulmonology
2002
177
45
Reduced neurocognition in children who snore
Pediatric Pulmonology
2004
173
46
Novel tobramycin inhalation powder in cystic fibrosis subjects: Pharmacokinetics and safety
Pediatric Pulmonology
2007
173
47
European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations
Pediatric Pulmonology
2001
172
48
An 18‐month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis
Pediatric Pulmonology
2010
169
49
Detecting early structural lung damage in cystic fibrosis
Pediatric Pulmonology
2002
168
50
Sleep-disordered breathing in 3,680 Greek children
Pediatric Pulmonology
2004
168
site/software ©
exaly
; All materials licenced under
CC by-SA
.